Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teotten is a Spanish biotechnology company specializing in the assessment of T-cell mediated immunity through innovative diagnostic tools. Spun off from the Spanish National Research Council (CSIC), the company utilizes a proprietary platform to quantify cellular immune responses, offering a deeper understanding of long-term protection against pathogens compared to standard serological tests. Their primary commercial offering is a diagnostic test for SARS-CoV-2 immunity, which measures the activation of T-cells upon exposure to viral antigens. Teotten is currently leveraging its technology to develop diagnostic applications in oncology, organ transplantation, and other infectious diseases. The company's approach provides critical data for personalized medicine, helping clinicians determine the necessity of vaccine boosters and monitor immune health in immunocompromised patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Teotten Diagnostics.